Detalhe da pesquisa
1.
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.
Acta Oncol
; 62(7): 744-752, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039661
2.
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma.
Br J Haematol
; 193(3): 506-514, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620088
3.
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Haematologica
; 106(4): 1129-1137, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273476
4.
Interim thymus and activation regulated chemokine versus interim 18 F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation.
Br J Haematol
; 190(1): 40-44, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106342
5.
Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.
Br J Haematol
; 189(6): 1093-1106, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030738
6.
Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC.
Br J Haematol
; 175(5): 868-875, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27610595
7.
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739705
8.
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
J Clin Oncol
; : JCO2301386, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359378
9.
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Blood Cancer J
; 13(1): 130, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658062
10.
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
J Hematol Oncol
; 16(1): 104, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705050
11.
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.
Blood Adv
; 7(19): 5911-5924, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552109
12.
Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma.
Haematologica
; 97(3): 410-5, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058214
13.
Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome.
Cancers (Basel)
; 14(4)2022 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205758
14.
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP.
Leukemia
; 36(12): 2853-2862, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241696
15.
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis.
Eur J Cancer
; 176: 100-109, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208568
16.
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.
J Cancer Surviv
; 2022 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441393
17.
Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989-2017.
Leukemia
; 35(2): 494-505, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461630
18.
Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis.
Leuk Lymphoma
; 62(14): 3320-3332, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323643
19.
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study.
Blood Adv
; 5(15): 2958-2964, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338755
20.
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
J Natl Cancer Inst
; 113(6): 760-769, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351090